Cypress Capital Management LLC held its stake in Colgate-Palmolive (NYSE:CL) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,303 shares of the company’s stock at the end of the second quarter. Cypress Capital Management LLC’s holdings in Colgate-Palmolive were worth $245,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Pacer Advisors Inc. raised its holdings in Colgate-Palmolive by 8.4% during the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after purchasing an additional 1,566 shares in the last quarter. Alliancebernstein L.P. grew its position in Colgate-Palmolive by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock worth $139,014,000 after buying an additional 77,414 shares during the last quarter. Israel Discount Bank of New York acquired a new position in Colgate-Palmolive in the first quarter worth approximately $1,349,000. Principal Financial Group Inc. grew its position in Colgate-Palmolive by 0.6% in the first quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock worth $93,025,000 after buying an additional 7,905 shares during the last quarter. Finally, Personal Capital Advisors Corp grew its position in Colgate-Palmolive by 5.8% in the second quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock worth $29,209,000 after buying an additional 21,456 shares during the last quarter. 72.96% of the stock is currently owned by institutional investors.
Colgate-Palmolive (CL) traded down $0.34 during trading on Thursday, hitting $74.25. 2,698,300 shares of the stock traded hands, compared to its average volume of 3,606,011. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.27. The stock has a market cap of $65,497.87, a PE ratio of 25.99, a P/E/G ratio of 3.42 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same period in the previous year, the company posted $0.73 EPS. Colgate-Palmolive’s revenue was up 2.8% on a year-over-year basis. research analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.15%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.
In related news, Director Stephen I. Sadove sold 20,780 shares of Colgate-Palmolive stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the sale, the director now owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total transaction of $660,690.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 173,673 shares of company stock worth $12,629,293. 1.02% of the stock is currently owned by corporate insiders.
Several research analysts have issued reports on CL shares. Jefferies Group restated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Macquarie started coverage on shares of Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price target on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, September 20th. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $75.00 to $84.00 in a research report on Monday, September 25th. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $76.04.
COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Position Held by Cypress Capital Management LLC” was first reported by Stock Observer and is owned by of Stock Observer. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.thestockobserver.com/2017/12/07/colgate-palmolive-cl-position-held-by-cypress-capital-management-llc.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.